Autosomal dominant hereditary spastic paraplegia: Novel mutations in the REEP1 gene (SPG31)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2350
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Autosomal dominant hereditary spastic paraplegia: Novel mutations in the REEP1 gene (SPG31) ; volume:9 ; number:1 ; day:21 ; month:7 ; year:2008 ; pages:1-4 ; date:12.2008
BMC medical genetics ; 9, Heft 1 (21.7.2008), 1-4, 12.2008
- Creator
-
Schlang, Katharina J.
- Contributor
- DOI
-
10.1186/1471-2350-9-71
- URN
-
urn:nbn:de:1111-2016021835642
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schlang, Katharina J.
- Arning, Larissa
- Epplen, Jörg T.
- Stemmler, Susanne
- SpringerLink (Online service)
Other Objects (12)
High frequency of SPG4 in Taiwanese families with autosomal dominant hereditary spastic paraplegia
Expanding SPG18 clinical spectrum: autosomal dominant mutation causes complicated hereditary spastic paraplegia in a large family
Molecular analysis of the autosomal dominant spastic paraplegia type IV (SPG4)
Molecular analysis of the autosomal dominant spastic paraplegia type IV (SPG4)
Chinese families with autosomal recessive hereditary spastic paraplegia caused by mutations in SPG11
Translational research approaches in hereditary spastic paraplegia
Early-onset hereditary spastic paraplegia: case report
Neurometabolic Dysfunction in SPG11 Hereditary Spastic Paraplegia
Understanding disease modulators of SPG11‐linked hereditary spastic paraplegia.
Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients
The role of inflammation in hereditary spastic paraplegia type 11
Hereditary spastic paraplegia from 1880 to 2017: an historical review
High frequency of SPG4 in Taiwanese families with autosomal dominant hereditary spastic paraplegia
Expanding SPG18 clinical spectrum: autosomal dominant mutation causes complicated hereditary spastic paraplegia in a large family
Molecular analysis of the autosomal dominant spastic paraplegia type IV (SPG4)
Molecular analysis of the autosomal dominant spastic paraplegia type IV (SPG4)
Chinese families with autosomal recessive hereditary spastic paraplegia caused by mutations in SPG11
Translational research approaches in hereditary spastic paraplegia
Early-onset hereditary spastic paraplegia: case report
Neurometabolic Dysfunction in SPG11 Hereditary Spastic Paraplegia
Understanding disease modulators of SPG11‐linked hereditary spastic paraplegia.
Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients
The role of inflammation in hereditary spastic paraplegia type 11
Hereditary spastic paraplegia from 1880 to 2017: an historical review
High frequency of SPG4 in Taiwanese families with autosomal dominant hereditary spastic paraplegia
Expanding SPG18 clinical spectrum: autosomal dominant mutation causes complicated hereditary spastic paraplegia in a large family
Molecular analysis of the autosomal dominant spastic paraplegia type IV (SPG4)
Molecular analysis of the autosomal dominant spastic paraplegia type IV (SPG4)
Chinese families with autosomal recessive hereditary spastic paraplegia caused by mutations in SPG11
Translational research approaches in hereditary spastic paraplegia
Early-onset hereditary spastic paraplegia: case report
Neurometabolic Dysfunction in SPG11 Hereditary Spastic Paraplegia
Understanding disease modulators of SPG11‐linked hereditary spastic paraplegia.
Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients
The role of inflammation in hereditary spastic paraplegia type 11